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Disturbances in neuronal differentiation and function are an underlying factor of many brain disorders. Zinc homeostasis and
signaling are important mediators for a normal brain development and function, given that zinc deficiency was shown to result in
cognitive and emotional deficits in animal models that might be associated with neurodevelopmental disorders. One underlying
mechanism of the observed detrimental effects of zinc deficiency on the brain might be impaired proliferation and differentiation
of stem cells participating in neurogenesis. Thus, to examine the molecular mechanisms regulating zinc metabolism and signaling
in differentiating neurons, using a protocol for motor neuron differentiation, we characterized the expression of zinc homeostasis
genes during neurogenesis using human induced pluripotent stem cells (hiPSCs) and evaluated the influence of altered zinc levels
on the expression of zinc homeostasis genes, cell survival, cell fate, and neuronal function. Our results show that zinc transporters
are highly regulated genes during neuronal differentiation and that low zinc levels are associatedwith decreased cell survival, altered
neuronal differentiation, and, in particular, synaptic function. We conclude that zinc deficiency in a critical time window during
brain development might influence brain function by modulating neuronal differentiation.
1. Introduction
Zinc is an essential trace metal interacting with a plethora of
proteins. It plays a functional role in structural, regulatory,
and signaling processes and thus is essential for a healthy
brain. However, abnormally high levels of zinc are cytotoxic.
Therefore, zinc levels have to be highly regulated during
embryogenesis and development of the central nervous
system (CNS). It is thus not surprising that zinc deficiencies
can contribute to the occurrence of numerous human birth
defects involving CNS malformation [1, 2]. On a mechanistic
point of view, zinc has many roles in the developing and adult
brain [3]. For example, zinc is an essential catalytic compo-
nent of many different mammalian enzymes, such as DNA
and RNA polymerases and histone deacetylases [4] needed
for DNA replication and cellular proliferation. Additionally,
zinc-dependent enzymes such as metalloproteinases and
zinc-binding proteins such as metallothioneins (MTs) have a
function in metabolism and zinc signaling [5]. Furthermore,
many protein-protein interactions andDNA-binding proper-
ties of receptors [6] and transcription factors known to reg-
ulate key genes involved in cellular proliferation and neuro-
genesis aremediated by zinc-fingermotifs [7, 8]. Intriguingly,
maternal zinc deficiency has been identified as a risk factor for
the development of autism in the offspring [9]. Further, mice
exposed to zinc deficiency during brain development display
autism like behavior later in life [10, 11]. Therefore, zinc
signalingmight play a crucial role during brain development,
in particular neurogenesis and synaptogenesis, and by that
ultimately mediate correct circuit formation.
Cellular zinc homeostasis is regulated by transporters,
such asDMTs (divalentmetal transporters), ZnTs (zinc trans-
porters of the SLC30A family), and ZIP (Zrt-Irt-like proteins
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of the SLC39A family), and intracellular zinc-binding pro-
teins, in particular metallothioneins (MTs). Transmembrane
transporters mediate the uptake and removal of zinc and
transport of zinc into and out of intracellular organelles. ZnT
proteins transport zinc out of the cytosol and ZIP proteins
move zinc into the cytosol. Zinc binding in the cytosol is
mostly regulated by proteins of the MT family (MT-1, MT-
2, and MT-3), which bind zinc transiently and are therefore
able to provide zinc for signaling processes [12, 13].
It was reported that zinc may play a role in the control
of both developmental and adult neurogenesis mediated by
proliferating adult stem cells in the subgranular zone of the
dentate gyrus [14]. However, on a cellular level, the under-
lying mechanisms that regulate zinc homeostasis in differ-
entiating neurons and the influence of different zinc levels
on differentiation efficacy and nerve cell function after
differentiation are so far not well understood.
Here, we used human induced pluripotent stem cells
(hiPSC) as model system for neuronal differentiation to
determine the cellular consequences of altered zinc levels. To
that end we used iPS cells from keratinocytes of two healthy
controls [15]. iPS cells are somatic cells that can be repro-
grammed to a pluripotent state by gene transfer [16–18]. As
pluripotent stem cells, they can be differentiated into several
lineages, of which we choose a neuronal fate. We differen-
tiated iPS cells into neuronal precursor cells (NPCs) and
neurons using conditions that favor the generation of motor
neurons and evaluated the differential expression of zinc
homeostasis genes and outcomes of altered zinc levels.
2. Methods
2.1. Materials. DMEM/F12 + GlutaMAX, DPBS without
Ca2+/Mg2+, GlutaMAX, NEAA antibiotic-antimycotic, nat-
ural essential amino acids, knockout serum replacement,
BDNF, GDNF, IGF-1, B27, FBS, and N2 were purchased from
Gibco/Life Technologies. DPBS with Ca2+/Mg2+ was
obtained from PAA. mTeSR1 stem cell medium and dis-
pase were purchased from Stemcell Technologies. Purmor-
phamine was obtained from Calbiochem. Insulin was
obtained from SAFC. ROCK inhibitor was purchased from
Ascent Scientific and 𝛽-mercaptoethanol was purchased
from Millipore. HESC qualified matrigel was obtained from
BD Biosciences. Retinoic acid, poly-L-ornithine, laminin,
heparin sodium salt, sodium selenite, apotransferrin, putre-
scin, progesterone, acetylcholine, glutamate, GABA, glycine,
and NMDA were purchased from Sigma-Aldrich. Cycloth-
iazide was obtained from Tocris. Ultra-low attachment flasks
were purchased from Corning Costar and 𝜇-dishes (35mm,
low) were purchased from Ibidi. Chelex 100 resin was pur-
chased from Bio-Rad. Tissue-Tek® was obtained from Sakura.
The Apoptosis/Necrosis/Healthy Cell Detection kit was pur-
chased from PromoKine and ApoTox-Glo Triplex Assay was
purchased from Promega. Triton X-100 was procured from
Roche. RNeasy Mini and Micro kit, Quantitect primers,
QuantiFast SYBR Green RT-PCR kit, RT2 First Strand kit,
and customized RT2 profiler rotor-disks were obtained from
Qiagen. Primary antibodies were purchased from Synaptic
Systems (Homer1 1 : 500, Synaptophysin 1 : 500, and GRIA3
1 : 500), Abgent (CHRNA3 1 : 500), UC Davis/NIH Neu-
roMab Facility (GABA-A-R𝛼1 1 : 500), Covance (SMI-32
(NEFH) 1 : 1000), R&D Systems (active caspase-3 1 : 1000),
and Sigma-Aldrich (NMDAR1 1 : 500). Alexa Fluor-conju-
gated secondary antibodies were purchased from Invitrogen
(1 : 1000). Unless otherwise indicated, all other chemicals
were obtained from Sigma-Aldrich.
2.2. Cell Culture. IPS cell lines were generated by Linta et
al. as previously described [15]. iPS cells were cultured in
mTeSR1medium at 37∘C, 5%O
2
, and 5%CO
2
. Differentiation
into motor neurons was performed as previously described
by Hu and Zhang [19]. For the formation of embryoid bodies
(EB), iPS cells were cultured in suspension in hESC medium
(DMEM/F12 + 20% knockout serum replacement + 1%
NEAA+ 1% 𝛽-mercaptoethanol + 1% antibiotic-antimycotic)
in ultra-low attachment flasks (Corning Costar). ROCK
inhibitor was added for the first 48 h. Neurodifferentiation
was induced by changing the medium to (DMEM/F12 +
24 nM sodium selenite + 16 nM progesterone + 0.08mg/mL
apotransferrin + 0.02mg/mL insulin + 7.72 𝜇g/mL putrescin
+ 1% NEAA, 1% antibiotic-antimycotic + 50mg/mL heparin
+ 10 𝜇g/mL of the neurotrophic factors BDNF, GDNF, and
IGF-1) at e03. At e07 EB were plated on laminin coated
12-well plates. 0.1𝜇M of retinoic acid (RA) was added at
e09. At e14 neural rosettes (NR) were detached and cultured
in suspension with addition of 1 𝜇M purmorphamine. 2-3
neural stem cell (NSC) spheres were plated on a 35mm 𝜇-
dish (Ibidi) coated with poly-L-ornithine (PLO) and laminin.
Retinoid acid was reduced to 0.05𝜇M.Medium was changed
1x/week. Motor neurons were analyzed at d21 and d42 after
final plating.
2.3. Establishment of Different Zinc Conditions. Zinc defi-
cient medium was generated by depletion of all divalent
cations using Chelex 100 resin (Bio-Rad) as described by the
manufacturer and as previously published [20]. To that end
mTeSR1, hESC medium, and basal differentiation medium
were incubated with Chelex 100 beads that were subsequently
removed by centrifugation, a cell strainer, and sterile filtering
with 0.2𝜇m sterile filters. Original cation concentrations
were reestablished for all divalent cations present in neu-
robasal medium (0.247 𝜇M Fe
2
(NO
3
)
3
, 0.81mMMgCl
2
, and
1.8mM CaCl
2
) except for ZnSO
4
⋅4H
2
O. The original pH of
the medium was readjusted with HCl (mTeSR1 pH 8.2; hESC
basal pH 8.0; basal differentiation medium pH 7.5). Sup-
plemental factors were added to the zinc depleted medium
right before use. As a control condition, the original zinc
concentration of zinc depleted medium was reestablished.
Zinc supplemented medium was prepared by addition of
10 𝜇M ZnCl
2
to the original medium.
2.4. Preparation of Cryosections of NSC Spheres. NSC spheres
were fixed with 4% paraformaldehyde/10% saccharose and
washed three times with PBS and resuspended in 100 𝜇L
PBS. Tissue-Tek in small aluminium foil containers was snap-
frozen until it was viscous. NSC spheres were transferred
to the viscous Tissue-Tek and snap-frozen until everything
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was solid. 30 𝜇m cryosections were made at the cryostat.
Alternatively, NSC were live-stained using the Apoptosis/
Necrosis/Healthy Cell Detection kit (PromoKine) according
to the manufacturer’s instructions for suspension cells before
fixing. Staining time was enlarged to 45min to ensure pene-
tration of NSC spheres. Fixing and washing were performed
in buffers containing 1.25mM calcium-chloride to ensure
annexin V binding to phosphatidylserine.
2.5. Immunocytochemistry. For immunofluorescence, the
cultures were fixed with 4% paraformaldehyde/4% sucrose/
PBS at 4∘C for 20min and processed for immunocytochem-
istry. After washing 3 × 5min with 1x PBS, cells were perme-
abilized with 0.2% Triton X-100 for 5min at RT. Blocking was
performed with 5% FBS in 1x PBS for 1 h at RT, followed by
primary antibody incubation with at 4∘C overnight. After a 3
× 5min washing-step with 1x PBS, incubation with the Alexa
Fluor-coupled secondary antibody followed for 1 h. Cells were
mounted with ProLong® Gold antifade reagent either with or
without DAPI.
2.6.Metabolic Apoptosis Assay. Embryoid bodies (EB) grown
in zinc depleted or zinc replete conditions were harvested
and transferred to an opaque 96-well plate in different
dilutions with zinc depleted or zinc replete DMEM/F12 +
24 nM sodium selenite + 16 nM progesterone + 0.08mg/mL
apotransferrin + 0.02mg/mL insulin + 7.72 𝜇g/mL putrescin
+ 1% NEAA, 1% antibiotic-antimycotic + 50mg/mL heparin
+ 10 𝜇g/mL of the neurotrophic factors BDNF, GDNF, and
IGF-1 in a final volume of 100 𝜇L/well. Ethanol-treated EB
from the zinc repletion condition were used as a positive
control, and medium without cells was used as a blank.
The ApoTox-Glo Triplex Assay (Promega) was performed as
described in the manufacturer’s protocol. 20𝜇L of combined
substrates cell-permeant GF-AFC and cell-impermeant bis-
AAF-R110 in assay buffer was added to the cell solution
and incubated for 45min at 37∘C. Fluorescence was read
in a PerkinElmer 2030 Explorer at 405 nm (excitation) and
460 nm (emission) for viability and 485 nm (excitation) and
535 nm (emission) for cytotoxicity. 100 𝜇L of Caspase-Glo®
3/7 Substrate in Caspase-Glo® 3/7 Buffer was added to the
wells and incubated at 37∘C for 2 h. Luminescence was
read in a PerkinElmer 2030 Explorer. Viability/cytotoxicity
ratios were not significantly different. Apoptotic cells were
normalized to number of viable cells.
2.7. Quantitative Real-Time PCR. Isolation of total RNA from
iPS cells in different stages of motor neuron differentia-
tion was performed using the RNeasy Mini kit (Qiagen)
as described by the manufacturer including all additional
purification steps. For the reverse transcriptase-mediated
PCR studies, first strand synthesis and real-time quantitative
RT-PCR amplification were carried out in a one-step, single-
tube format using the QuantiFast SYBR Green RT-PCR kit.
Thermal cycling and fluorescent detection were performed
using the Rotor-Gene-Q real-time PCR machine (model 2-
Plex HRM) (Qiagen). The qRT-PCR was assayed in 0.1mL
strip tubes in a total volume of 20𝜇L reaction mixture
containing 1 𝜇L of undiluted total RNA, 2𝜇L of QuantiTect
Primer Assay oligonucleotides, 10 𝜇L of 2x QuantiFast SYBR
Green RT-PCR Master Mix supplemented with ROX (5-
carboxy-X-rhodamine) dye, and 6.8 𝜇L of RNase-free water
and 0.2 𝜇L of QuantiFast RT Mix. Amplification conditions
were as follows: 10min at 55∘C and 5min at 95∘C, followed
by 40 cycles of PCR for 5 s at 95∘C for denaturation and
10 s at 60∘C for annealing and elongation (one-step). The
SYBR Green I reporter dye signal was measured against
the internal passive reference dye (ROX) to normalize non-
PCR-related fluctuations. Resulting data were analyzed uti-
lizing the hydroxymethylbilane synthase (HMBS) gene as
an internal standard to normalize transcript levels through
all stages of differentiation. Cycle threshold (ct) values were
calculated by the Rotor-Gene Q software (version 2.0.2). All
qRT-PCR reactions were run in biological triplicate for each
cell line. To ascertain primer specificity a melting curve was
obtained for the amplicon products to determine their melt-
ing temperatures. Real-time quantitative PCR was carried
out using oligonucleotides allowing to investigate expression
of NEFH as well as MT2A, MT3, MTF1, ProSAP1/Shank2,
ProSAP2/Shank3, Shank1, ZnT1, ZnT2, ZnT3, ZnT4, ZnT5,
ZnT6, ZIP1, and ZIP3 (validated primer pairs, Quantitect
primer assay, Qiagen). The set of zinc homeostasis and other
zinc-related genes included in the analyses of this study
was chosen based on a literature search for reports on the
expression and function of specific zinc transporters and
zinc-binding genes in the brain and spinal cord [21–25].
For high-throughput screening of synaptic genes total
RNA was isolated using the RNeasy Mini kit according to
the manufacturer’s manual. All additional purification steps
were performed and RNA eluted in a total of 15 𝜇L RNAse-
free water. Genomic DNA elimination and cDNA synthesis
were performed with 800 ng RNA using the RT2 First Strand
Kit (Qiagen) as described by the manufacturer. Quantitative
real-time PCR screening was performed using the RT2 SYBR
Green qPCR Mastermix and customized RT2 profiler rotor-
disks with preimmobilized primers (Qiagen #CAPA9600-
12:CAPH13069R) according to the manufacturer’s protocol
in a reaction volume of 20𝜇L. Ct values were calculated
by the Rotor-Gene Q software as previously described and
normalized to NEFH as an internal standard for mature
motor neurons.
2.8. Microscopy. Fluorescence images were obtained with an
upright Axioscope microscope equipped with a Zeiss CCD
camera (16 bits; 1280 × 1024 ppi) using Axiovision software
(Zeiss) and analyzed using Axiovision and ImageJ (v1.49o)
software.
2.9. Electrophysiology. Single cell patch-clamp electrophys-
iology of motor neurons d42 after plating was performed
using intracellular buffer (140mM KCl, 2mM MgCl
2
, 4mM
EGTA, 4mM ATP⋅2Na, and 10mM HEPES; pH 7.2) and
extracellular buffer (145mM NaCl, 5mM KCl, 1mM MgCl
2
,
1.5mM CaCl
2
, 6mM glucose, and 12mM HEPES; pH 7.4).
Standard parameters like resting membrane potential, mem-
brane resistance, serial resistance, cell size (capacitance using
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the 𝑐-slow compensationmethod and the “sine + dc”method
according to Lindau and Neher [26]), synaptic currents
(voltage clampmode), synaptic events (current clampmode),
and half-width as well as peak height after AP induction were
assessed. In addition cells were stimulated either with 100𝜇M
acetylcholine, 500 𝜇M glutamate, 10 𝜇M GABA, and 500 𝜇M
glutamate along with 100 𝜇M cyclothiazide or with 50𝜇M
NMDA along with 10 𝜇M glycine (switch to Mg free buffer).
2.10. Statistics. Statistical analysis was performed using Mic-
rosoft Excel, GraphPad Prism 5, and SPSS with a significance
level set to 0.05 (∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01; ∗∗∗𝑝 ≤ 0.001).
According to the parameters tested, values were analyzed for
normal distribution and Student’s 𝑡-test or 1-way ANOVA
with subsequent post hoc analysis (Tukey’s multiple compar-
ison test) was performed. Only in case no iPSC line specific
differenceswere detected, values fromboth lineswere pooled.
3. Results
3.1. Expression of Zinc Homeostasis Genes during Stem Cell
Differentiation into Motor Neurons. iPS cells from two con-
trol cell lines were differentiated to motor neurons using
a well-characterized protocol [19, 27] (Figure 1(a)). Identity
of motor neurons was confirmed by the motor neuronal
marker NEFH. To investigate whether specific zinc home-
ostasis genes are developmentally regulated, we determined
the mRNA expression levels of selected zinc homeostasis
genes and the zinc-dependent SHANK genes that have been
associatedwith autism spectrumdisorders (ASD) [28] during
neuronal differentiation in various stages (iPS cells, embryoid
bodies, neural rosettes, neural stem cells, andmotor neurons)
(Figure 1(b)). Several zinc transporters show developmental
stage-dependent expression as well as altered expression lev-
els during differentiation.While ZIP1 and ZIP3 are expressed
on similar level throughout all stages of motor neuron
differentiation, the expression of transporters from the ZnT
family shows more variations. In particular, an increase in
ZnT4 expression from iPS cells to motor neurons can be
detected. In addition, the expression of ZnT1 is significantly
increased in motor neurons at d42 compared to the iPS cell
stage. The expression of ZnT3 is very low in early stages
but also significantly increases in immature motor neurons
and remains elevated in mature motor neurons. Similarly, no
expression of ZnT4was detected in iPS cells, butmRNA levels
gradually increase from EB to motor neurons, which can
also be observed for ZnT5 expression. Additionally, mRNA
levels of ZnT6 were found to be significantly higher in motor
neurons compared to iPS cells. In contrast, ZnT2 expression
was only detected in NSC (Figure 1(b)).
Zinc homeostasis is regulated not only by the influx and
efflux of zinc via transporters, but also by buffering of zinc
due to zinc-binding proteins.Metallothioneins (MTs) thereby
play a crucial role. The expression of MTs is regulated in
response to the zinc levels present inside cells. This process
is mediated by the transcription factor MTF1. Interestingly,
themRNA level ofMTF1 itself is significantly higher inmotor
neurons compared to iPS cells.
The expression ofMT2A, apart from some variance in iPS
cells, is low during all stages of motor neuron development
compared to adult motor neurons at d42. Thus, MT2A
expression very specifically significantly increases in motor
neurons between d21 and d42.The expression ofMT3 in turn
was only detected in NSC and motor neurons but not in ear-
lier stages, which is in line with the CNS specific expression
pattern of MT3 [29]. No significant difference was detected
between young and old motor neurons (Figure 1(b)). Finally,
proteins of the SHANK family have been shown to bind zinc
(Shank2 and Shank3) [10, 30, 31] and are key proteins of
synapses in the CNS and also occur at neuromuscular junc-
tions [32]. Interestingly, although SHANK proteins are asso-
ciated with synapses that only occur in differentiated motor
neurons, their expression can be already detected in iPS
cells and later stages of motor neuron differentiation, hinting
towards an additional role outside postsynaptic densities
(PSDs) [33]. Particularly SHANK3 seems to be expressed on
similar level throughout differentiation. In contrast, although
also expressed in each stage, mRNA levels of SHANK1 and
SHANK2 seem to increase towards later stages (Figure 1(b)).
Comparing not only the expression of a single gene
between different developmental stages but also the general
expression levels between genes (Figure 1(c)), expression
levels of ZnT1 and ZnT6 were the highest compared to
other ZnTs across all stages of motor neuron differentiation.
Similarly, ZIP1 expression was comparably high through-
out all phases of differentiation. Zinc supplementation
(10 𝜇M ZnCl
2
during all stages) does not significantly alter
the expression of the aforementioned genes compared to
untreated controls (see Figure S1 in Supplementary Material
available online at http://dx.doi.org/10.1155/2016/3760702)
with the exception of MT2A in old motor neurons.
3.2. Zinc Deficiency Affects Expression of Zinc Homeostasis
Genes during Stem Cell Differentiation into Motor Neurons.
Given that, under physiological conditions, the blood brain
barrier (BBB) tightly regulates brain zinc levels protecting
the brain from abnormally high zinc concentrations, zinc
deficiency might likely occur during pregnancy [34], leading
to alterations in brain development of the offspring [35,
36]. Thus, in the next set of experiments, we compared
expression levels of the zinc homeostasis genes previously
investigated under zinc depleted and zinc replete (control)
conditions. To that end cells were exposed to medium that
was previously zinc depleted using Chelex-100 beads or
zinc replete medium as a control condition throughout all
stages of neurodifferentiation (Figure 2). Our results show
that zinc deficiency leads to gene and differentiation stage-
dependent changes. Zinc deficiency leads to a decrease of
ZnT1 expression in motor neurons at d42, and a significant
upregulation of ZnT5 expression in motor neurons at d21
and less so at d42. The expression of ZIP1 was significantly
decreased in the NSC stage under zinc deficient conditions,
while the expression of MT3 significantly increased. Again
expression levels of SHANK proteins were sensitive for
altered zinc concentrations in the medium. The expression
of SHANK1 significantly increased in motor neurons at d21
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Figure 1: Continued.
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Figure 1: Expression of zinc homeostasis genes during stem cell differentiation into motor neurons. (a) Quantitative evaluation of mRNA
expression levels normalized to HMBS of selected zinc homeostasis and the zinc-dependent SHANK genes. Analyses were performed in
triplicate (𝑛 = 3) and the mean normalized expression is shown. Neurofilament H (NEFH) expression was used to control successful
differentiation and increases significantly inNRs and rises again after a significant decrease inNSC in suspension (iPSC versusNR:𝑝 = 0.0028;
NR versus NSC: 𝑝 = 0.0175). Several zinc transporters show developmental stage-dependent expression as well as altered expression levels
during differentiation. Expression of ZnT1 is significantly increased in motor neurons at d42 compared to the iPS cell stage (𝑝 = 0.0086).
ZnT2 expression in turn was only detected above background in NSC. Expression of ZnT3 is very low in early stages (iPS, EB, and NR) but
increases in NSC and becomes significant in motor neurons (iPSC versus MN d21: 𝑝 = 0.0239) in which ZnT3 levels remain elevated. No
expression of ZnT4 was detected in iPS cells, but mRNA levels gradually increase from EB to motor neurons (EB versus MN d42: 𝑝 = 0.0352;
NR versus MN d21: 𝑝 = 0.0384). This is also observed for ZnT5 expression; however it is only seen as trend. Additionally, the expression of
ZnT6 was found to be significantly higher in motor neurons compared to iPS cells (iPS versus MN d42: 𝑝 = 0.0178). Along with the increase
in expression of some zinc transporters during motor neuron differentiation, the mRNA levels of MTF1 are significantly higher in motor
neurons compared to iPS cells (iPSC versus MN d42: 𝑝 = 0.0074; NSC versus MN d42: 𝑝 = 0.0170; MN d21 versus MN d42: 𝑝 = 0.0263).
While ZIP1 and ZIP3 are expressed on similar level through all stages of motor neuron differentiation, the expression of MT2A shows some
variance in iPSC but otherwise is significantly higher in motor neurons compared to most previous stages and significantly increases in
motor neurons between d21 and d42 (EB versusMN d42: 𝑝 = 0.0347; NSC versusMN d42: 𝑝 = 0.0474; MN d21 versusMN d42: 𝑝 = 0.0397).
The expression of MT3 in turn could only be detected in NSC and motor neurons but not in earlier stages. Although SHANK proteins are
associated with synapses that only occur in motor neurons, their expression can be already detected in iPS cells and later stages of motor
neuron differentiation. SHANK1 and SHANK2 expression increases towards later stages (SHANK1: iPSC versus NR: 𝑝 = 0.0225; iPSC versus
MN d21: 𝑝 = 0.0327) (SHANK2: EB versus MN d42: 𝑝 = 0.0061; NR versus MN d42: 𝑝 = 0.0132; MN d21 versus MN d42: 𝑝 = 0.0017),
although the expression of SHANK2 in iPS cells shows high variability. SHANK3 is expressed on similar level throughout differentiation.
(b) Representative images of hiPSC undergoing differentiation to motor neurons (MN) via the generation of embryoid bodies (EB), neural
rosettes (NR), and neural stem cells (NSC). (c) Comparison of mRNA expression levels across different zinc homeostasis genes. In general,
expression levels of ZnT1 and ZnT6 were the highest compared to other ZnTs across all developmental stages. Similarly, ZIP1 expression was
high throughout all phases of motor neuron differentiation, while MTF1 and MT2A expression increased in old motor neurons. ∗𝑝 ≤ 0.05;
∗∗𝑝 ≤ 0.01.
and of SHANK3 in neural rosettes under zinc deficient con-
ditions.
3.3. Zinc Deficiency Significantly Impairs iPS Cell Differen-
tiation. To understand the biological consequences of the
observed alterations, we analyzed the capacity of stem cells
to undergo successful neuronal differentiation under zinc
deficient conditions in neuronal stem cells (NSC) and embry-
oid bodies (EB) (Figure 3). While the average size of NSC
clusters was not significantly altered upon zinc deficiency
(Figure 3(a)), the number of NSC clusters was significantly
reduced in zinc deficient conditions (Figure 3(b)) indicating
a reduction in cell survival. However, we could not detect a
significant increase in markers for apoptosis or necrosis at
the NSC stage (Figure 3(c)). Apoptotic cells were identified
using annexinV labeledwith FITC, necrotic cells by ethidium
homodimer III, and the total number of cells was assessed
using Hoechst labeling.The analysis of the amount of cleaved
caspase-3 shows an increase of cleaved caspase-3 in NSC
grown under zinc deficient conditions, which is seen as a
trend (Figure 3(d)). Activation of caspase-3 requires cleavage
of its inactive form into activated p17 and p12 fragments,
activating downstream processes of apoptosis. The amount
of cleaved caspase-3 thus provides a read-out for initiated
apoptosis.
Since we did not detect significantly increased cell death
at the NSC stage, cell survival seems impaired already at ear-
lier stages.This was confirmed by analysis of EB (Figure 3(e)).
Here, we found a significant increase in the number of cells
undergoing apoptosis in cells grown under zinc deficient
conditions compared to controls.
3.4. Altered Zinc Levels Affect Glutamatergic Neuronal Dif-
ferentiation and Neuronal Function. Finally, to investigate
whether zinc deficiency does influence not only cell survival
but also the fate and developmental endpoints of cells during
differentiation,we first analyzed differentiatedmotor neurons
regarding their morphology (Figure S2) and functionality
using electrophysiological read-outs (Figure 4). We stained
motor neurons for the motor neuronal marker NEFH, the
postsynaptic marker Homer1, and the presynaptic marker
synaptophysin as well as DAPI for nuclear labeling. Mor-
phological analysis of motor neurons derived from iPS cells
grown under control and zinc supplemented conditions did
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Figure 2: Zinc deficiency alters the expression of zinc homeostasis genes during stem cell differentiation into motor neurons. Quantitative
evaluation of mRNA expression levels normalized to HMBS of selected zinc homeostasis and the zinc-dependent SHANK genes. Data shows
the average normalized gene expression based on 𝑛 = 6measurements. Neurofilament H (NEFH) expression was used to control successful
differentiation. For statistical analysis, a 1-way ANOVAwas used followed by Tukey’s multiple comparison test. Several zinc transporters show
expression levels depending on the availability of zinc in the medium. Comparing cells grown in zinc depleted medium with cells grown in
medium which was resupplemented with zinc in the amount used in control medium after zinc depletion, a significant difference in ZnT1
expression was found in d42motor neurons (one-way ANOVA: 𝑝 < 0.0001; MN d42 Ctrl versus −Zn: 𝑝 < 0.05). No significant difference was
detected regarding the expression of ZnT2, ZnT3, ZnT4, ZnT6, and MTF1 comparing controls and zinc deficient conditions. The expression
of ZnT5 was significantly increased in motor neurons at d21 under zinc deficient conditions (one-way ANOVA: 𝑝 < 0.0001; MN d21 Ctrl
versus −Zn: 𝑝 < 0.05). The expression of ZIP1 was significantly reduced in neuronal stem cells under zinc deficient conditions (one-way
ANOVA: 𝑝 = 0.0012; NSC Ctrl versus −Zn: 𝑝 < 0.05). The expression of ZIP3 was not found to be altered, similar to the expression levels
of MT2A. MT3 expression was significantly higher in neuronal stem cells under zinc deficient conditions (one-way ANOVA: 𝑝 < 0.0001;
NSC Ctrl versus −Zn: 𝑝 < 0.05). The expression of SHANK1 was increased in motor neurons at d21 under zinc deficient conditions (one-way
ANOVA: 𝑝 < 0.0001; MN d21 Ctrl versus −Zn: 𝑝 < 0.05) and the expression of SHANK3 in neural rosettes under zinc deficient conditions
(one-way ANOVA: 𝑝 < 0.0001; NR Ctrl versus −Zn: 𝑝 < 0.05). No change was observed for SHANK2 expression. ∗∗𝑝 ≤ 0.01; ∗∗∗𝑝 ≤ 0.001.
not reveal any significant differences regarding soma size
(Figure S2A), the number of primary dendrites (Figure S2B),
and the number of synapses (Figure S2C). Using single cell
patch-clamp electrophysiology, a significant difference in
resting potentials was detected between cells grown under
zinc deficient and zinc supplemented conditions (Figure 4(a))
as well as a significant difference in cell size assessed by
capacitance measurements using the 𝑐-slow compensation
method and the “sine + dc” method according to Lindau and
Neher [26] (Figure 4(b)) and the number of ion channels
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Figure 3: Zinc deficiency significantly impairs iPS cell differentiation. (a) The average size of NSC clusters is not significantly altered upon
zinc deficiency. (b) The mean number of NSC clusters per area measured on a 10 cm petri dish is significantly reduced in zinc deficient
conditions (𝑡-test, 𝑝 = 0.0281; 𝑛 = 8). (c) Apoptosis and necrosis were evaluated for the NSC stage during differentiation. No difference in
the number of cells labeled with markers for apoptosis or necrosis was found between zinc deficient and zinc sufficient media (𝑡-test, 𝑛 = 20).
Right panel: exemplary images of NSC stained with annexin V labeled with FITC (apoptotic cells) and ethidium homodimer III (necrotic
cells) and DAPI (total number of cells). (d) The mean number of cells showing signals specific for cleaved caspase-3 was increased under
zinc deficient conditions seen as trend (𝑡-test, 𝑝 = 0.09; 𝑛 = 20). Right panel: exemplary images of NSC stained with anti-active caspase-3
antibody and DAPI. (e) A significant increase in apoptotic cells was detected in embryoid bodies grown under zinc deficient conditions using
the ApoTox-Glo™ Triplex Assay (𝑡-test, 𝑝 = 0.0098; 𝑛 = 12). ∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01.
active or existent as assessed by membrane resistance, both
hinting towards a slightly more immature phenotype (Fig-
ure 4(c)).There was an increase in resting potential negativity
in zinc depleted cells. The cells did not show any significant
differences in the half-width of induced action potentials and
sodium currents that could confirm a larger difference in
maturity (Figures 4(d) and 4(e)).
During electrophysiological measurements, all cells were
measuredwithin the same buffer with physiological zinc con-
centration.We detected a significant increase in acetylcholine
(ACh) induced currents in cells grown under zinc deficient
conditions (Figure 4(f)). In contrast, a decrease in glutamate
(Glut) induced currents can be seen under zinc deficient
conditions (Figure 4(g)).
To further elucidate the alterations in glutamate signaling,
we investigated AMPAR and NMDAR currents in the cells
grown under different zinc levels. We observed a reduction
in both AMPAR and NMDAR currents (Figures 4(h) and
4(i)) and also detected a reduction in GABAR currents
(Figure 4(j)) after differentiation of cells in zinc depletion
conditions. In line with these results, the number of cells
showing ACh induced currents was higher in zinc deficient
conditions (Figure 4(k)), while the number of cells showing
Glut induced currents was significantly less when compared
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Figure 4: Altered zinc levels affect glutamatergic signaling. (a) Representative image of a neuron used for patch-clamp electrophysiological
studies (left panel). Right panel: a significant difference in resting potentials was detected between cells grown under zinc deficient and zinc
supplemented conditions (𝑡-test, 𝑝 = 0.0028; 𝑛 = 19: Ctrl
−Zn and −Zn, 𝑛 = 32: Ctrl+Zn, and 𝑛 = 42: +Zn). (b) A significant difference in
membrane capacity was detected between cells grown under zinc deficient and zinc supplemented conditions (𝑡-test, Ctrl
−Zn versus −Zn,
𝑝 = 0.0228; Ctrl
+Zn versus +Zn, 𝑝 = 0.0273; −Zn versus +Zn, 𝑝 = 0.0016; 𝑛 = 19: Ctrl−Zn and −Zn; 𝑛 = 32: Ctrl+Zn, 𝑛 = 42: +Zn). (c)
A significant difference in membrane resistance was detected between cells grown under zinc deficient and zinc supplemented conditions
(𝑡-test, Ctrl
−Zn versus −Zn, 𝑝 = 0.0445; −Zn versus +Zn, 𝑝 = 0.0018; 𝑛 = 19: Ctrl−Zn and −Zn; 𝑛 = 32: Ctrl+Zn; 𝑛 = 42: +Zn). (d) Single
cell patch-clamp electrophysiology did not show any significant differences in the half-width of induced action potentials (AP) and sodium
currents (e). (f) A significant increase in acetylcholine (ACh) induced currents was observed in zinc deficient cells when compared to zinc
supplemented cells (𝑡-test, −Zn versus +Zn, 𝑝 = 0.050; 𝑛 = 19: Ctrl
−Zn and −Zn, 𝑛 = 32: Ctrl+Zn, and 𝑛 = 42: +Zn). (g) A decrease in
glutamate (Glut) induced currents can be seen under zinc deficient conditions as trend. (h) AMPAR currents and NMDAR currents (i) as
well as GABAR currents (j) were significantly decreased after differentiation of cells in zinc depletion conditions (𝑡-test, AMPAR, 𝑝 = 0.0186;
NMDAR, 𝑝 = 0.0099; GABAR, 𝑝 = 0.0067; 𝑛 = 19: Ctrl
−Zn, 𝑛 = 18: −Zn, 𝑛 = 31: Ctrl+Zn, and 𝑛 = 41: +Zn). (k) The number of cells showing
ACh induced currents was higher in zinc deficient conditions. (l) The number of cells showing Glut induced currents was significantly less
under zinc deficient conditions when compared to zinc supplemented cells (contingency (Chi square) test, 𝑝 = 0.0113). The fraction of cells
with Glut induced currents was also significantly increased in zinc supplemented cells compared to controls (contingency (Chi square) test,
𝑝 = 0.04) (𝑛 = 19: Ctrl
−Zn, 𝑛 = 18: −Zn, 𝑛 = 31: Ctrl+Zn, and 𝑛 = 41: +Zn). (m)The fraction of cells with AMPAR currents (m) and NMDAR
currents (n) as well as GABAR currents (o) was decreased after differentiation of cells in zinc depletion conditions (contingency (Chi square)
test, AMPAR, 𝑝 = 0.0031; NMDAR, 𝑝 = 0.089; GABAR, 𝑝 = 0.0198; 𝑛 = 19: Ctrl
−Zn; 𝑛 = 17-18: −Zn). All currents were normalized to cell
size. #trend (𝑝 value between 0.05 and 0.1). ∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01.
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to zinc supplemented cells (Figure 4(l)). In addition, the
fraction of cells displaying AMPAR, NMDAR (as a trend), or
GABAR currents was significantly decreased in cells of the
zinc depletion condition (Figures 4(m)–4(o)).
Given that the observed shift hints towards a reduction
in glutamatergic and GABAergic neurotransmission favor-
ingACh signaling, we evaluated expression of synaptic recep-
tors. A screening for the expression of genes associated with
glutamatergic and cholinergic neurotransmission as well as
synapse plasticity revealed a decrease of ACh recep-
tors, mainly CHRNA3, CHRNA5, CHRNA7, CHRNA9,
and CHRNA10, while an increase in metabotropic gluta-
mate receptor expression (GRM2, GRM3, and GRM5) was
observed (Figure 5(a)). As the alterations might reflect a
compensatory mechanism in response to reduced zinc levels
and are not reflected by the functional read-outs, we further
investigated whether the altered gene expression is translated
into changes on protein levels. To that end, we performed
analyses of fluorescent signal intensity and measured the
amount of immunoreactive signals after immunocytochem-
istry (Figures 5(b) and 5(c)). Under reduced zinc conditions,
we could detect a significant decrease in the number of
gamma-aminobutyric acid (GABA) receptor 1 (GABRA1)
signals per dendrite and a decrease in GABRA1 fluorescent
signal intensity correlating with the amount of protein
present. Further, we could detect a reduction in the protein
concentration of ionotropic glutamate (AMPA) receptor 3
(GRIA3), which however was only found significant in one
iPSC line. No alterations were detected in GRIN1 (ionotropic
glutamate (NMDA) receptor 1) and CHRNA3 (nicotinic
cholinergic receptor, alpha 3).
4. Discussion
The global prevalence of zinc deficiency with estimated
31% [37] may have significant effects on brain development,
cognition, and neurological diseases, in particular those that
might be caused by an impaired glutamatergic signaling such
as autism spectrum disorders [38, 39].
Here, we found that the expression of genes mediating
zinc homeostasis and signaling is endogenously regulated
during motor neuronal differentiation and provide a detailed
data-set for gene expression of a subset of zinc transporter
genes and zinc-binding proteins during stem cell differen-
tiation into motor neurons. These regulatory processes are
likely both to occur as reaction to altered demands for zinc
in specific differentiation stages and to enable zinc signaling,
which, for example, is involved in processes such as apoptosis.
In line with this, we could show that insufficient zinc supply
has an effect on cell survival and by that reduces the number
of neuronal stem cells differentiating from iPSC. It has been
previously reported that zinc deficiency can affect neuronal
cell precursor proliferation by the induction of apoptosis via
p53-mediated processes [3, 40, 41].
Given this important role of adequate zinc supply for
neurogenesis, it is not surprising that physiological responses
exist to tightly regulate zinc levels during neuronal differen-
tiation. Indeed, we observed a response in gene expression
of zinc homeostasis genes under zinc deficient conditions.
For example, a reduction of the zinc exporter ZnT1 as
observed in mature motor neurons will lead to increased
retention of zinc inside the neuron. Reduced ZnT1 levels were
already observed in neonatal rats exposed to zinc deficiency
[42]. Similarly, reduced expression of ZnT5 in young motor
neurons may reduce zinc export into cell organelles and
thereby ameliorate the decrease in cytoplasmic zinc. Such a
responsiveness of ZnT5 to zinc deficiency was also shown
with in THP1 cells [43]. In contrast, an increase in MT3 as
observed in NSC under zinc depletion might increase the
ability to retain and buffer zinc inside the cell. A moderate
increase ofMT3 expression in response to zinc deficiency was
reported before in rats [44]. However, a great variability of
these alterations during the different stages of neuronal differ-
entiation hints towards highly dynamic compensatory pro-
cesses and/or further regulatory processes on protein level.
In case of an inability to compensate low zinc levels such
as in our experimental conditions, not only is the number
of neuronal stem cells decreased but also differentiated
motor neurons show significant differences when compared
to motor neurons that differentiated under zinc adequate
conditions. The differences we observed cannot be explained
by alterations of NMDAR, AMPAR, GABAR, or acetyl-
choline esterase by the neuromodulatory function of zinc,
as all measurements were performed using the same buffer
that contained physiological zinc concentrations. Thus, the
differences must be based on developmentally acquired
variances and are not due to acute alterations in zinc levels. In
particular, we observed an increase in ACh signaling under
zinc deficient conditions. This increase was seen both on
the level of ACh induced currents and in the total number
of cells responsive to ACh stimulation. More prominent,
glutamatergic signaling was impaired under zinc deficient
conditions. Again both a reduction in glutamate induced
currents (both AMPAR and NMDAR currents) and a reduc-
tion in the total number of cells responding to glutamate
stimulationwere observed under zinc deficient conditions. In
addition, GABAR currents and the fraction of cells displaying
GABAR currents were significantly reduced. The results can
be explained by an increase in the number of cholinergic
synapses per neuron and a reduction of glutamatergic and
GABAergic synapses per neuron and/or a strengthening of
existing synapses. Indeed, we found a decrease of GABRA1
immunoreactive signals per dendrite as well as a reduction of
GRIA3 levels per synapse supporting this model. We did not
observe a significant increase in CHRNA3 signals. However,
the CHRNA family alone consists of 10 members encoding
for different subunits and more detailed analyses are needed
in future studies. For example, on mRNA level, we observed
mixed effects of neuronal differentiation under zinc deficient
conditions on the cholinergic system. Here, the expression
of many CHRNA family members was decreased under zinc
deficient conditions, while the expression of CHRNA2 and 6
and CHRNB3 was increased.
Gene transcription was also found to be increased for
some members of the glutamatergic and GABAergic system,
such as GABRA1 and GRIA3 under zinc deficient conditions,
where we detected a decrease of synaptic signals on protein
level. It might be speculated that neuronal differentiation
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Figure 5: Cells differentiated under different zinc levels show altered gene expression and protein levels of neurotransmitter receptors. (a)
A screening for the expression of genes associated with glutamatergic and cholinergic neurotransmission as well as synapse plasticity reveals
a decrease of ACh receptors, mainly CHRNA3, CHRNA5, CHRNA7, CHRNA9, and CHRNA10, while an increase in glutamate receptor
expression (GRM2, GRM3, and GRM5; GRIA3; GRIN2A) was observed. (b) Immunocytochemical analysis of 𝑛 = 20 cells per condition.
The mean number of signals per dendrite length was assessed. No differences were detected for CHRNA3, GRIN1, and GRIA3. A significant
reduction was seen for GABRA1 signals (𝑡-test, 𝑝 = 0.05). (c) Immunocytochemical analysis of 𝑛 = 20 cells per condition. The mean signal
intensity per fluorescent puncta was assessed. No differences were detected for CHRNA3 and GRIN1. A significant reduction of GABRA1
signal intensity (𝑡-test, 𝑝 = 0.022) was observed. GRIA3 signal intensity was reduced only in one cell line (𝑡-test, 𝑝 = 0.0045). ns: not
significant. ∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01.
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under zinc deficient conditions may result in a mislocaliza-
tion of the proteins rather than decrease of total protein that
cannot be overcome even upon increased gene transcription.
Here, we only assessed synaptic protein concentrations. It is
known, for example, that some synaptic glutamate receptors
are dependent on a zinc sensitive PSD scaffold of SHANK2
and SHANK3 proteins for synaptic localization [10, 28].
Thus, it might be possible that zinc signals play a role in
the establishment of neuronal subtype identity. Intriguingly,
an excess of cholinergic neurons was found in the basal
forebrain of autistic children [45] and nicotinic cholinergic
antagonists have been reported beneficial in autism [46].
Although there are similarities in neuronal subtypes as pre-
viously discussed, here we used motor neurons as a model-
neuron. It is possible that zinc signaling is regulated and
involved in the differentiation of stem cells into other neu-
ronal subtypes in alternative fashion.
Taken together, neurogenesis is an essential first step of
the development of the CNS. The influence of zinc ions on
cell differentiation and neuronal function can be complex
and manifold and might span the whole spectrum from cell
differentiation into mature neurons, followed by synapto-
genesis, to synaptic pruning. In addition, programmed cell
death is an important factor contributing to CNS develop-
ment. Insufficient supply with zinc thereby might influence
processes such as DNA replication, transcriptional control,
mRNA translation, apoptosis, and microtubule stability [3,
47, 48].Thus, zinc signaling and zinc levels need tight control
by zinc transporters and buffering proteins. We conclude
that sufficient supply with the essential trace metal zinc
might be especially relevant during the time window of brain
development and maternal zinc status might be a critical
factor to secure healthy mental functioning. However, these
findings might also be relevant to adult neurogenesis, as
dietary zinc deprivation, zinc chelation, and depletion of
vesicular zinc in ZnT3 knockout mice all lead to a significant
decrease in hippocampal progenitor cell proliferation also in
adult animal models [49].
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